Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Gatell

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|June 16, 2011
Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapyJosep M Llibre, José R Arribas, Pere Domingo, et al.
AIDS (London, England)|June 8, 2017
Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patientsMarta Montserrat, Montserrat Plana, Alberto C Guardo, et al.
Medicina Clinica|August 1, 2007
[Adverse side effects of antiretroviral therapy: relationship between patients' perception and adherence]María Teresa Martín, Elena del Cacho, Ester López, et al.
AIDS Research and Human Retroviruses|March 28, 2013
Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³Constanza Lucero, Berta Torres, Agathe León, et al.
Antiviral Therapy|October 7, 2003
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophyOscar Miró, Sònia López, Enric Pedrol, et al.
Antiviral Therapy|February 2, 2012
Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudineVicens Diaz-Brito, Agathe León, Hernando Knobel, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|September 6, 2016
Cost-effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different componentsJosep M Llibre, Elisa de Lazzari, Jean-Michel Molina, et al.
Current HIV Research|March 12, 2009
Polymorphic receptors of the innate immune system (MBL/MASP-2 and TLR2/4) and susceptibility to pneumococcal bacteremia in HIV-infected patients: a case-control studyJuan P Horcajada, Francisco Lozano, Ana Muñoz, et al.
AIDS (London, England)|January 16, 2008
Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adultsJosep Mallolas, Judith Pich, María Peñaranda, et al.
AIDS Research and Human Retroviruses|December 18, 2003
Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapyOscar Miró, Sònia López, Esteban Martínez, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|June 16, 2011
Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapyJosep M Llibre, José R Arribas, Pere Domingo, et al.
AIDS (London, England)|June 8, 2017
Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patientsMarta Montserrat, Montserrat Plana, Alberto C Guardo, et al.
Medicina Clinica|August 1, 2007
[Adverse side effects of antiretroviral therapy: relationship between patients' perception and adherence]María Teresa Martín, Elena del Cacho, Ester López, et al.
AIDS Research and Human Retroviruses|March 28, 2013
Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³Constanza Lucero, Berta Torres, Agathe León, et al.
Antiviral Therapy|October 7, 2003
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophyOscar Miró, Sònia López, Enric Pedrol, et al.
Antiviral Therapy|February 2, 2012
Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudineVicens Diaz-Brito, Agathe León, Hernando Knobel, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|September 6, 2016
Cost-effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different componentsJosep M Llibre, Elisa de Lazzari, Jean-Michel Molina, et al.
Current HIV Research|March 12, 2009
Polymorphic receptors of the innate immune system (MBL/MASP-2 and TLR2/4) and susceptibility to pneumococcal bacteremia in HIV-infected patients: a case-control studyJuan P Horcajada, Francisco Lozano, Ana Muñoz, et al.
AIDS (London, England)|January 16, 2008
Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adultsJosep Mallolas, Judith Pich, María Peñaranda, et al.
AIDS Research and Human Retroviruses|December 18, 2003
Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapyOscar Miró, Sònia López, Esteban Martínez, et al.
Pageof 7